Biogena Group Invest Ag (BIO.VI) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

—

Levered DCF

—

After debt service

Piotroski score

—

Altman Z-score

—

Rating

—

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
P/E	0×	0×	0×	39.36×	16×	68.21×
P/B	0×	0×	0×	0×	1.33×	3.65×
P/S	0×	0×	0×	0×	34.71×	24.17×
EV / EBITDA	-0.08×	-0.04×	-0.13×	-0.08×	14.05×	51.37×
Gross margin	100.0%	100.0%	99.5%	99.7%	99.8%	100.0%
Operating margin	51.0%	53.2%	2.1%	37.1%	-22.9%	12.1%
Net margin	83.6%	89.7%	103.8%	118.8%	222.1%	35.4%
Current ratio	26.35×	6.31×	3.79×	11.5×	24.4×	6.11×
Debt / equity	0×	0×	0×	0×	0×	0×
Interest coverage	0×	0×	19.04×	76,359.84×	-28,838.4×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	1.3%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	19.7%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Return on equity	3.3%	3.8%	2.0%	3.5%	8.5%	5.4%
Return on invested capital	2.0%	2.2%	0.0%	1.1%	-0.8%	1.4%
Return on assets	3.3%	3.7%	1.9%	3.4%	8.4%	5.1%
Free cash flow yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Earnings yield	0.0%	0.0%	0.0%	0.0%	6.4%	1.5%
Enterprise value	-€23.6K	-€12.3K	-€23K	-€24.5K	€11.5M	€7.8M
Net debt / EBITDA	-0.08×	-0.04×	-0.13×	-0.08×	-0.02×	-1.36×
Cash conversion cycle (days)	0	1,400	2,807	1,123	-12,684	0